Invesco Pharmaceuticals ETF Rating $85.63 +1.69 (+2.01%) Closing price 08/8/2025 04:10 PM EasternExtended Trading$85.62 0.00 (-0.01%) As of 08/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.69Holdings in PJP have an aggregate rating of Moderate Buy based on 336 analyst ratings issued in the past year covering 25 companies (88.0% of the portfolio).PJP Aggregate Price Target$85.63High Prediction$85.63Average Prediction$85.63Low Prediction$85.63Holdings in PJP have an aggregate price target of $85.63 and a range of $85.63 to $85.63 covering 25 companies (88.0% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PJP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.19%LLYEli Lilly and Company$625.15-2.5%4.9992 of 5 stars2.67$984.41 57.5%21Trending NewsEarnings ReportAnalyst DowngradeInsider TradeGap UpHigh Trading Volume5.18%PFEPfizer$24.57+1.4%4.985 of 5 stars2.39$28.12 14.4%18Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision5.16%MRKMerck & Co., Inc.$80.73+0.4%4.997 of 5 stars2.35$107.44 33.1%20Positive News5.08%AMGNAmgen$288.23+1.2%4.4972 of 5 stars2.33$303.76 5.4%21Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision4.97%GILDGilead Sciences$119.41+8.3%4.6443 of 5 stars2.80$114.82 -3.8%25Trending NewsEarnings ReportDividend AnnouncementAnalyst UpgradeGap UpHigh Trading Volume4.91%ABBVAbbVie$198.10-0.4%4.6872 of 5 stars2.93$214.43 8.2%27Trending News4.88%JNJJohnson & Johnson$173.40+1.1%4.6919 of 5 stars2.65$174.50 0.6%20Positive News4.80%ABTAbbott Laboratories$134.41+1.8%4.9086 of 5 stars2.91$144.47 7.5%22Positive News4.05%OCULOcular Therapeutix$12.21-0.7%3.6235 of 5 stars3.00$17.20 40.9%5Earnings ReportAnalyst Revision3.14%LGNDLigand Pharmaceuticals$150.06+2.6%3.3821 of 5 stars3.00$157.00 4.6%6Trending NewsEarnings ReportAnalyst Forecast2.98%AMRXAMNEAL PHARMACEUTICALS$8.54+4.0%3.453 of 5 stars3.00$11.60 35.8%5Earnings Report2.92%ANIPANI Pharmaceuticals$81.48+18.1%3.218 of 5 stars3.00$83.25 2.2%9Trending NewsEarnings ReportAnalyst ForecastGap UpHigh Trading Volume2.87%COLLCollegium Pharmaceutical$34.93+6.0%3.569 of 5 stars2.67$44.33 26.9%3Trending NewsAnalyst UpgradeHigh Trading Volume2.80%VTRSViatris$9.70+3.3%1.7946 of 5 stars1.80$10.40 7.2%5Trending NewsEarnings ReportDividend AnnouncementAnalyst UpgradeHigh Trading Volume2.78%TVTXTravere Therapeutics$16.94+0.2%1.9979 of 5 stars2.87$32.21 90.2%15Earnings ReportAnalyst ForecastAnalyst Revision2.75%AVDLAvadel Pharmaceuticals$12.75+0.1%2.7534 of 5 stars3.00$18.67 46.4%6News CoveragePositive NewsEarnings ReportAnalyst ForecastAnalyst Revision2.70%BIIBBiogen$130.67+2.3%4.9123 of 5 stars2.34$185.63 42.1%32Analyst Revision2.66%JAZZJazz Pharmaceuticals$111.30-0.7%4.3719 of 5 stars2.93$181.43 63.0%14Trending NewsEarnings Report2.65%HRMYHarmony Biosciences$34.194.6153 of 5 stars3.00$51.00 49.2%10Trending NewsEarnings ReportAnalyst DowngradeAnalyst Revision2.65%BMYBristol Myers Squibb$45.96+1.3%4.6206 of 5 stars2.24$56.38 22.7%21Positive NewsAnalyst Downgrade2.62%SUPNSupernus Pharmaceuticals$41.23-0.6%1.976 of 5 stars2.67$41.00 -0.6%3News CoverageAnalyst ForecastInsider Trade2.61%INVAInnoviva$18.34-0.7%4.2382 of 5 stars3.00$40.33 119.9%3News CoverageEarnings ReportAnalyst Revision2.60%PRGOPerrigo$22.62-0.9%4.6792 of 5 stars2.40$33.00 45.9%5Trending NewsEarnings ReportHigh Trading Volume2.57%TARSTarsus Pharmaceuticals$47.85-0.2%2.373 of 5 stars3.00$66.67 39.3%7Positive NewsEarnings ReportAnalyst Revision2.49%UTHRUnited Therapeutics$301.50+0.7%4.9565 of 5 stars2.69$379.69 25.9%13Positive NewsInsider Trade This page (NYSEARCA:PJP) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale